go to contents

Akribes Biomedical GmbH

Back to list

Facts

Founded
Staff
5
Organization type
RDM medtech

Profile

Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.

Similar companies in RDM medtech

DIOPTEX Medizinprodukte Forschungs-, Entwicklungs- und Vertriebs GmbH

Organization type
RDM medtech
Region
Upper Austria
Topic
electromechanical medical devices
opthalmic and optical devices
diagnostic and therapeutic radiation devices
resuable devices
non-active implantable devices
telemedicine and e-health
software for medicine
Details

JEDER GmbH

Organization type
RDM medtech
Region
Vienna
Cluster
ecoplus
Topic
dental devices
single-use devices
resuable devices
Details

SHL Solutions for Healthcare and Life-Sciences GmbH

Organization type
RDM medtech
Region
Lower Austria
Topic
telemedicine and e-health
software for medicine
Details

surgebright GmbH

Organization type
RDM medtech
Region
Upper Austria
Cluster
Medical Technology Cluster
Topic
biological-derived devices
single-use devices
resuable devices
non-active implantable devices
Details

Contact



Contact: